For therapeutic application, silencing lncRNA like NMRK2 mRNA could inhibit the cell growth and mitochondrial function of UOK109 cells and suppress the tumor progression of NONO-TFE3 rRCC. The gene discussed is TFE3; the disease is neoplasm.